{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:45:22Z","timestamp":1790163922361,"version":"4.1.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"C","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Among women, breast cancer (BC) is the most prevalent type of cancer and the top cause of cancer deaths. Although non-Hodgkin lymphoma (NHL) is the most prevalent hematological cancer, it is rarely reported synchronous with BC. Moreover, which malignancy appears first can rarely be explained because they are usually detected incidentally while diagnosing and treating other malignancies. This paper reports a case of invasive ductal carcinoma (IDC) concomitant with NHL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Presentation of case:<\/jats:title>\n                    <jats:p>A 35-year-old woman presented with simultaneous IDC in the left breast and NHL in a lymph node in the neck. The patient underwent a modified radical mastectomy for stage IIIA IDC and received rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy for stage I NHL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical discussion:<\/jats:title>\n                    <jats:p>Treating BC and NHL remains challenging due to their significantly different management, the lack of guidelines for treating BC and lymphoma simultaneously, and uncertainty about whether synchronous tumors should be treated separately as distinct clinical entities or as one disease with treatment covering both. Therefore, the best approach continues to be focusing on the most biologically aggressive malignancies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The enlargement of lymph nodes not in the lymphatic drainage of the primary tumor should be suspected of indicating multiple primary malignancies until proven otherwise. For patients with luminal-B BC, NHL chemotherapy can involve receiving the R-CHOP regimen, including doxorubicin and cyclophosphamide, which can help to mitigate BC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Highlights<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1016\/j.ijscr.2022.107398","type":"journal-article","created":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T02:12:25Z","timestamp":1657332745000},"page":"107398","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Synchronous breast cancer and non-Hodgkin lymphoma"],"prefix":"10.1097","volume":"97","author":[{"given":"Salman Ardi","family":"Syamsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rino","family":"Setiady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilam","family":"Smaradania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Prihantono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Febie","family":"Irsandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Faruk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-28-20260309","first-page":"5","article-title":"Epidemiology of non-Hodgkin's lymphoma","volume":"9","author":"Thandra","year":"2021","journal-title":"Med. Sci. (Basel, Switzerland"},{"key":"R3-28-20260309","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4048\/jbc.2014.17.1.91","article-title":"Concurrent invasive ductal carcinoma of the breast and malignant follicular lymphoma, initially suspected to be metastatic breast cancer: a case report","volume":"17","author":"Hahm","year":"2014","journal-title":"J. Breast Cancer"},{"key":"R4-28-20260309","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ijsu.2020.10.034","article-title":"The SCARE 2020 guideline: updating consensus Surgical CAse REport (SCARE) guidelines","volume":"84","author":"Agha","year":"2020","journal-title":"Int. J. Surg"},{"key":"R5-28-20260309","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"R6-28-20260309","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/annonc\/mdx097","article-title":"International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017)","volume":"28","author":"Younes","year":"2017","journal-title":"Ann. Oncol"},{"key":"R7-28-20260309","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/jamaoncol.2015.3113","article-title":"Performance status in patients with cancer","volume":"1","author":"West","year":"2015","journal-title":"JAMA Oncol"},{"key":"R8-28-20260309","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1472-6947-13-72","article-title":"Appraisal of the Karnofsky Performance Status and proposal of a simple algorithmic system for its evaluation","volume":"13","author":"P\u00e9us","year":"2013","journal-title":"BMC Med. Inform. Decis. Mak"},{"key":"R9-28-20260309","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.7150\/jca.25482","article-title":"Multiple primary malignant tumors - a clinical analysis of 15,321 patients with malignancies at a single center in China","volume":"9","author":"Zhai","year":"2018","journal-title":"J. Cancer"},{"key":"R10-28-20260309","doi-asserted-by":"crossref","first-page":"131","DOI":"10.5582\/irdr.2021.01017","article-title":"Synchronous occurrence of breast cancer and refractory diffuse large B-cell abdominal lymphoma: management and review of the literature","volume":"10","author":"Salemis","year":"2021","journal-title":"Intractable Rare Dis. Res"},{"key":"R11-28-20260309","first-page":"69","article-title":"Multiple primary malignancies-epidemiological analysis at a single tertiary institution","volume":"19","author":"Irimie","year":"2010","journal-title":"J. Gastrointestin. Liver Dis"},{"key":"R12-28-20260309","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/sj.bjc.6604241","article-title":"Second malignancies after breast cancer: the impact of different treatment modalities","volume":"98","author":"Kirova","year":"2008","journal-title":"Br. J. Cancer"},{"key":"R13-28-20260309","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1477-7819-12-88","article-title":"Synchronous invasive ductal carcinoma and intravascular large B-cell lymphoma of the breast: a case report and review of the literature","volume":"12","author":"Ho","year":"2014","journal-title":"World J. Surg. Oncol"},{"key":"R14-28-20260309","first-page":"336","article-title":"Non-Hodgkin's lymphoma in women with breast cancer.","volume":"6","author":"Wiernik","year":"n.d.","journal-title":"Cancer J"},{"key":"R15-28-20260309","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/85499","article-title":"Epstein-Barr virus nuclear protein EBNA-3C interacts with the human metastatic suppressor Nm23-H1: a molecular link to cancer metastasis","volume":"7","author":"Subramanian","year":"2001","journal-title":"Nat. Med"},{"key":"R19-28-20260309","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J. Clin. Oncol"},{"key":"R22-28-20260309","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1470-2045(21)00758-0","article-title":"Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials","volume":"23","author":"Bradley","year":"2022","journal-title":"Lancet Oncol"}],"container-title":["International Journal of Surgery Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261222006447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261222006447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1016\/j.ijscr.2022.107398","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T09:02:32Z","timestamp":1773046952000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1016\/j.ijscr.2022.107398"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":16,"journal-issue":{"issue":"C","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1016\/j.ijscr.2022.107398","relation":{},"ISSN":["2210-2612"],"issn-type":[{"value":"2210-2612","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]}}}